BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 9, 2018
View Archived Issues
Plugging leaks in engineered vasculature
Read More
Activin signaling underscores resistance to platinum-based chemotherapy in lung adenocarcinoma
Read More
The exerkine apelin reverses age-associated sarcopenia
Read More
First participant enrolled in phase III study of M-001 universal flu vaccine candidate
Read More
Immunose FLU nasal influenza vaccine candidate demonstrates good safety in older adults
Read More
Phase III study of Estelle oral contraceptive meets primary efficacy endpoint
Read More
Bayer patents MKNK1 inhibitors
Read More
Researchers present new NR1I2 agonists
Read More
Medshine Discovery synthesizes WEE1hu inhibitors
Read More
Description of a phase I study evaluating locoregional immunotherapy for ovarian cancer recurrence
Read More
Positive data announced from phase II extension study of MVA-BN RSV universal vaccine
Read More
FDA approves Poteligeo for two subtypes of cutaneous T-cell lymphoma
Read More
Identification of genetic prognosticators in glioblastoma survivors by NGS
Read More
Positive topline data presented from the pivotal phase III SONICS study of Recorlev
Read More
Ambys and Takeda to pioneer first-in-class therapies for the treatment of serious liver diseases
Read More
CBT Pharmaceuticals obtains ethics approval in Australia for APOLLO-1 study
Read More
Sangamo reports positive preliminary data from Alta study of gene therapy for hemophilia A
Read More
Phase I study of EGFR CAR T-cell immunotherapy opens
Read More